2014, a record year for US FDA approvals: orphan drugs, anti-PD-1s and 2nd chancers the winners
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration's Center for Drug Evaluation and Research in 2014 had its best year in drug approvals since 1996 – clearing 41 new molecular entities (NMEs) and novel biologics over the past 12 months.